Results 181 to 190 of about 59,772 (269)

Lack of Evidence for the Efficacy of Antifungal Medications to Treat Atopic Dermatitis: A Systematic Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is characterised by immune dysregulation and skin‐barrier dysfunction, which can predispose to microbial dysbiosis and skin infections. Fungi, particularly Malassezia, are common skin colonisers in AD patients and may exacerbate the condition.
Luis F. Andrade   +8 more
wiley   +1 more source

The Impact of Anesthesia on Dermatological Outcomes: A Narrative Review. [PDF]

open access: yesCureus
Islam RK   +6 more
europepmc   +1 more source

Designing diversity: ethical virtual agents for effective dermatological training

open access: gold
Melisa Kujević   +4 more
openalex   +1 more source

Management of Mild‐to‐Moderate Atopic Dermatitis With Topical Treatments by Dermatologists: A Questionnaire‐Based Study

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic, immune‐mediated, inflammatory skin disorder affecting a heterogeneous population. Most patients with mild‐to‐moderate AD are treated with topical medication. Objectives To gain an understanding of the management of mild‐to‐moderate AD with topical treatments by examining the practices of ...
Lawrence F. Eichenfield   +14 more
wiley   +1 more source

Verrucous psoriasis and current treatments: a review of the literature. [PDF]

open access: yesArch Dermatol Res
Rahman SM   +4 more
europepmc   +1 more source

Successful Psoriasis Management With Deucravacitinib After Guselkumab‐Associated Eosinophilic Pneumonia

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Eosinophilic pneumonia (EP) involves the accumulation of eosinophilic infiltrates in the lung parenchyma, potentially triggered by smoking, infections, or medications, including biologics for psoriasis. This case report describes a 49‐year‐old female with a history of psoriasis and chronic pancreatitis, who developed EP after initiating ...
Katie K. Lovell, Steven R. Feldman
wiley   +1 more source

Interleukin‐12/23 and Interleukin‐23 Inhibitors for the Treatment of Cutaneous Crohn's Disease: A Case Series From a Multi‐Institutional Registry

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Cutaneous Crohn's disease (CCD) is a granulomatous condition of the skin discontiguous from the gastrointestinal tract. Cutaneous disease rarely correlates with intestinal disease and often requires separate treatment. While the use of interleukin‐12/23 (IL‐12/IL‐23) and interleukin‐23 (IL‐23) inhibitors is FDA‐approved for ...
G. E. McKay   +14 more
wiley   +1 more source

Diagnosis and Management of Skin Toxicities in Systemic Treatment of Genitourinary Cancers. [PDF]

open access: yesCancers (Basel)
Chowdhury D   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy